1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. DR. REDDY'S LABORATORIES LTD.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124

Mid-range Performer
Download real time

1308.50 17.90 (1.39%)

28.28% Gain from 52W Low

594.8K NSE+BSE Volume

NSE 06 Jun, 2025 10:53 AM (IST)

Watchlist

Portfolio

Alert

Share
23S
4W
9O
3T
109,196.1

Market Cap

High in industry
19.3

PE TTM

Below industry Median
14

PEG TTM

PEG TTM is much higher than 1
3.6

Price to Book

Above industry Median
0.7

Beta 1Year

Very Low volatility
Partnership
Dr. Reddy's Lab and Alvotech to co-develop Keytruda biosimilar drug, with sales of $29.5 bn in 2024 See details

Analyze undervaluation/ overvaluation of Dr. Reddy's Laboratories Ltd. with current and 1 Year Forward PE

INSIGHT
Dr. Reddy's Laboratories Ltd. is undervalued at both current PE and future earnings estimates
Right Now : Current PE vs 5 year Average PE
Undervalued
Fair price

Based on 5Yr Average PE

1890.6
Upside

Current PE versus 5Yr Average PE

44.49 %
1 Year Forward : 5 Yr Average PE & Projected 1Yr Forward EPS*
Undervalued
Fair price

Based on 1Yr Forward EPS

1899.4
Upside

5 Yr Average PE & 1Yr Forward EPS

45.16 %
Info: The Dr. Reddy's Laboratories Ltd.'s current PE is 19.31 ,while its 5 year PE average is 27.9. Its forward PE based on analyst estimates is 19.2
Note: The forward P/E ratio (or forward price-to-earnings ratio) is calculated by dividing the current share price of a company by the estimated(1Yr) future (“forward”) earnings per share (EPS) of that company.
generated report

Analyze undervaluation/ overvaluation of Dr. Reddy's Laboratories Ltd. with historical PE and PBV ratios

Need Help?

from 06 Jun, 2023 to 05 Jun, 2025

Standalone P/E

Buy Zone

29.8% into P/E buy sell zone

% time spent below current P/E
0 20 40 60 80 100
Strong upside potential
Gains already realized

Out of 496 days, Dr. Reddy's Laboratories Ltd. traded 148 (29.8%) days below the current P/E of on Standalone basis.

Consolidated P/E

Sell Zone

60.3% into P/E buy sell zone

% time spent below current P/E
0 20 40 60 80 100
Strong upside potential
Gains already realized

Out of 496 days, Dr. Reddy's Laboratories Ltd. traded 299 (60.3%) days below the current P/E of on Consolidated basis.

Note: This is a reverse percentile score. Values close to 100% are bad while values close to 0% are good. Days when PE is negative are not considered in the analysis
60.3%

Sell Zone

% Days traded below current P/E

19.3
 

Current P/E

17.3
 

Average P/E

18.9
 

Median P/E

1899.4
 

Forward 1Y Price

19.2
 

Forward PE

68.1
 

Forward EPS

P/E range Days traded in range % Days traded in range Days traded within & below range % Days traded within & below range
3-4
 32 6.5% 32 6.5%
4-5
 28 5.6% 60 12.1%
5-18
 79 15.9% 139 28.0%
18-19
 121 24.4% 260 52.4%
19-20
Current P/E is 19.3 Forward PE is 19.22 		141 28.4% 401 80.8%
20-22
 95 19.2% 496 100.0%
Total 496 496
29.8%

Buy Zone

% Days traded below current P/E

20.4
 

Current P/E

22.2
 

Average P/E

24.7
 

Median P/E

1899.4
 

Forward 1Y Price

19.2
 

Forward PE

68.1
 

Forward EPS

P/E range Days traded in range % Days traded in range Days traded within & below range % Days traded within & below range
4-5
 54 10.9% 54 10.9%
5-19
 51 10.3% 105 21.2%
19-24
Current P/E is 20.4 Forward PE is 19.22 		95 19.2% 200 40.3%
24-25
 72 14.5% 272 54.8%
25-26
 78 15.7% 350 70.6%
26-27
 70 14.1% 420 84.7%
27-28
 27 5.4% 447 90.1%
28-35
 49 9.9% 496 100.0%
Total 496 496

FAQ

  • What is the PE ratio?

    In its simplest definition, the price-to-earnings ratio (P/E ratio) represents the price an investor pays per rupee of a company's earnings.
    For example, if a company has a P/E ratio of 25, investors are willing to pay INR 25 for each rupee of the company's current earnings. This indicates that investors value the stock at 25 times its current earnings, with an expectation of future earnings growth.
    The P/E ratio fluctuates based on investor sentiment towards a company. Positive sentiment drives the stock price higher, resulting in a higher P/E ratio (investors pay more for each rupee of earnings). Conversely, negative sentiment lowers the P/E ratio (investors pay less for each rupee of earnings).

  • What is the PE buy/sell zone?

    The PE buy/sell zone is calculated based on how many days a stock has traded at its current PE level.
    To do this, we compare the current PE to the stock’s historical PE performance, to find out how often (for how many days in the past) the stock has traded at its current PE value.
    If the stock has usually traded above its current PE level (it’s at a higher PE for the majority of trading days), then the stock is cheaper than usual and in the PE buy zone.
    If the stock has usually traded below its current PE level (it’s at a lower PE for the majority of trading days), then the stock is more expensive than usual and in the PE sell zone.

  • How is the PE buy sell zone useful?

    The PE buy sell zone tells you if a stock’s current PE level is unusually high or low, and if a stock doesn’t typically trade at that level. It helps investors identify stocks that are undervalued or overvalued in terms of their typical PE trading behavior.
    Investors should keep in mind that the buy zone/sell zone is not a foolproof buy or sell signal. For example, the PE of a stock may have fallen substantially due to adverse events or negative news. Or the PE may have risen sharply after the company has won new orders, made an acquisition, announced a buyback, or some other positive event. PE Buy/Sell Zone signals should be looked at in conjunction with other information.

  • Why are the number of days different for Standalone and Consolidated data?

    This can be because of any of the 2 following reasons:
    1. Days when PE is negative are not considered in the analysis. So if only 1 of the Standalone or Consolidated PE is negative and the other is not, then the days will be different
    2. Companies have reported Consolidated data for limited period.
Buy Sell Stock Screeners